Patients News | pharmaphorum

News

Pfizer partners American Cancer Society on health equity

A new $15 million initiative between Pfizer and the American Cancer Society (ACS) aims to tackle one of the most pressing issues in health at the moment – unequal access t

News

Meet Xaia, Cedars-Sinai's eXtended-Reality Artificially Intelligent Ally, now available on Apple Vision Pro

Cedars-Sinai mental health app launches on Apple Vision Pro

Right after the official launch of the new Apple Vision Pro mixed reality headset, Cedars-Sinai has launched a generative artificial intelligence (GenAI) app that will use

News

First patient treated with Moderna's PD-1/IDO1 cancer shot

The first patient has been treated in a phase 1/2 clinical trial of an experimental Moderna vaccine designed to generate antibodies against PD-L1 and IDO1 – two targets th

News

Hikma will pay $150m in US opioid settlement

Indian drugmaker Hikma has agreed in principle to a $150 million settlement to resolve lawsuits claiming that it contributed to the opioid crisis in the US, which could al

News

Global cancer burden study reveals ‘striking inequity’

The World Health Organization (WHO) has said that the burden of cancer on societies around the world is growing at an alarming rate, with a 77% increase in new cases expec

News

AbbVie’s Tepkinly backed by NICE for DLBCL patients

AbbVie’s CD20xCD3 bispecific antibody Tepkinly has been recommended by NICE for NHS use as a treatment for relapsed or refractory diffuse large B-cell lymphoma (DLBCL), an

Pfizer partners American Cancer Society on health equity

Cedars-Sinai mental health app launches on Apple Vision Pro

First patient treated with Moderna's PD-1/IDO1 cancer shot

Hikma will pay $150m in US opioid settlement

Global cancer burden study reveals ‘striking inequity’

AbbVie’s Tepkinly backed by NICE for DLBCL patients

Ultragenyx to slash costs after Angelman trial failure

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks